Institut Hospitalo-universitaire Méditerranée Infection, Marseille, France; Aix Marseille Université, Institut de Recherche pour le Développement, Assistance Publique-Hôpitaux de Marseille, Microbes Evolution Phylogénie et Infections, Marseille, France.
Institut Hospitalo-universitaire Méditerranée Infection, Marseille, France; Aix Marseille Université, Institut de Recherche pour le Développement, Assistance Publique-Hôpitaux de Marseille, Service de Santé des Armées, Vecteurs - Infections Tropicales et Méditerranéennes, Marseille, France; Centre d'Epidémiologie et de Santé Publique des Armées, Marseille, France; Assistance Publique - Hôpitaux de Marseille, Marseille, France.
Int J Antimicrob Agents. 2020 May;55(5):105947. doi: 10.1016/j.ijantimicag.2020.105947. Epub 2020 Mar 19.
SARS-CoV-2, the novel coronavirus from China, is spreading around the world, causing a huge reaction despite its current low incidence outside China and the Far East. Four common coronaviruses are in current circulation and cause millions of cases worldwide. This article compares the incidence and mortality rates of these four common coronaviruses with those of SARS-CoV-2 in Organisation for Economic Co-operation and Development countries. It is concluded that the problem of SARS-CoV-2 is probably being overestimated, as 2.6 million people die of respiratory infections each year compared with less than 4000 deaths for SARS-CoV-2 at the time of writing.
新型冠状病毒(SARS-CoV-2)来自中国,目前正在全球传播,尽管其在中国和远东以外的发病率较低,但仍引起了巨大反响。目前有四种常见的冠状病毒在流行,并在全球范围内导致数百万人感染。本文比较了这四种常见冠状病毒与经济合作与发展组织国家中 SARS-CoV-2 的发病率和死亡率。结论认为,SARS-CoV-2 问题可能被高估了,因为每年有 260 万人死于呼吸道感染,而截至撰写本文时,SARS-CoV-2 的死亡人数不到 4000 人。